Homology Medicines, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
8.14
|
|
Average Rating
|
4.10
|
|
# Strong Buys
|
5
|
|
# Buys
|
1
|
|
# Holds
|
4
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.47
|
-0.59
|
-0.12
|
-25.53%
|
|
2022-06-30
|
-0.56
|
-0.51
|
0.05
|
8.93%
|
|
2022-03-31
|
-0.35
|
1.59
|
1.94
|
554.29%
|
|
2021-12-31
|
-0.59
|
-0.59
|
0.00
|
0.00%
|
|
2021-09-30
|
-0.60
|
-0.54
|
0.06
|
10.00%
|
|
2021-06-30
|
-0.59
|
-0.54
|
0.05
|
8.47%
|
|
2021-03-31
|
-0.67
|
-0.02
|
0.65
|
97.01%
|
|
2020-12-31
|
-0.68
|
-0.62
|
0.06
|
8.82%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
0.49
|
|
2021-12-31
|
-1.69
|
|
2020-12-31
|
-2.80
|
|
2019-12-31
|
-2.47
|
|
2018-12-31
|
-5.47
|
|
2017-12-31
|
-0.32
|